Clinical Trial Update: Ivonescimab in the Treatment of Multiple Advanced Tumors [Phase 2]

View source ↗

Summary

An update indicating Ivonescimab is being studied in a Phase 2 trial for multiple advanced tumors and is currently recruiting. The trial covers several cancer t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumor
• Paraganglioma
• Penile Cancer
• Pheochromocytoma
• Prostate Cancer
• Renal Cell Carcinoma
• Rhabdomyosarcoma
• Urothelial Carcinoma

Drugs mentioned

• Ivonescimab (AK112/SMT112)

Snippet

Sponsor: Fudan University | Conditions: Pheochromocytoma/Paraganglioma, Rhabdomyosarcoma | Phase 2 | Status: RECRUITING